Omada Health, Inc. Annual Report - A Deeper Dive for Investors

Welcome, investors! Dive into Omada Health's pivotal year. This summary distills the key insights from the company's latest 10-K filing for the year ended December 31, 2025, offering a comprehensive look at its performance as a newly public entity.

The Big Leap: Omada Health Goes Public

Omada Health made a significant leap in 2025, completing its Initial Public Offering (IPO) on June 9. The company successfully listed its shares on The Nasdaq Stock Market LLC under the ticker symbol OMDA, raising approximately $150 million in net proceeds after underwriting discounts and commissions. This capital infusion will fuel product innovation, expand market reach, and strengthen Omada's financial position, accelerating its growth in digital chronic care management.

Understanding Omada's Public Status

As a newly public company, Omada Health falls into specific categories:

• Non-accelerated Filer: With a public float below $75 million, Omada has extended deadlines for filing its annual and quarterly reports. While this offers some operational flexibility, investors may receive financial updates later than from larger companies.
• Emerging Growth Company (EGC): This designation, for companies with less than $1.235 billion in annual gross revenue, allows Omada to benefit from reduced reporting requirements. Notably, Omada chose not to use the extended transition period for new accounting standards, demonstrating a proactive commitment to stricter financial reporting.

---

1. Business Overview

Omada Health, Inc. is a leading digital health company that prevents and manages chronic diseases. The company offers evidence-based, personalized digital care programs, helping individuals improve health outcomes for conditions like type 2 diabetes, hypertension, and obesity. Omada's programs combine professional health coaching, connected devices, and a proprietary digital platform to deliver engaging and effective interventions. Omada primarily partners with large employers, health plans, and health systems to offer its programs to their eligible populations, aiming to reduce healthcare costs and improve overall population health.

---

2. Financial Performance

Omada Health achieved significant growth in 2025, though profitability remains a key focus:

• Revenue: Total revenue surged to $285 million, a substantial 35% increase from $211 million in 2024. Increased adoption of its digital health programs and an expanding client base primarily drove this growth. Service revenue comprised $260 million (91% of total), with hardware revenue contributing $25 million.
• Gross Profit: Gross profit rose to $190 million in 2025, up from $135 million in 2024, reflecting a healthy 66.7% gross margin.
• Net Loss: Despite strong revenue growth, Omada reported a net loss of $65 million for 2025, compared to a net loss of $78 million in 2024. This reflects continued investment in growth initiatives, particularly in research and development (R&D) and sales and marketing (S&M), as the company scales.
• Key Expenses:
  • Research & Development (R&D): Increased to $70 million (24.6% of revenue) as Omada invests in platform enhancements and new program development.
  • Sales & Marketing (S&M): Rose to $110 million (38.6% of revenue) to expand market penetration and acquire new enterprise clients.
  • General & Administrative (G&A): Grew to $75 million (26.3% of revenue), partly due to increased costs associated with being a public company.

---

3. Risk Factors

While Omada Health shows promising growth, investors should be aware of several key risks:

• Customer Concentration: Omada significantly relies on a few key partners. The filing highlights two major partners, "Partner A" and "Partner B," which collectively accounted for approximately 40% of total revenue and 45% of accounts receivable for the year ended December 31, 2025. This concentration poses a material risk; losing or significantly reducing business from either partner could materially impact Omada's financial results.
• Path to Profitability: Despite revenue growth, the company still operates at a net loss, and it may not achieve sustained profitability. Continued investment in growth initiatives, R&D, and S&M could delay profitability.
• Intense Competition: The digital health market is highly competitive, with numerous established players and new entrants. Omada competes with traditional healthcare providers, other digital health companies, and technology companies entering the healthcare space.
• Regulatory Environment: Changes in healthcare regulations, data privacy laws (e.g., HIPAA), or reimbursement policies could affect operations and financial performance. The evolving regulatory landscape for digital health solutions creates ongoing compliance challenges.
• Technology and Data Security: Omada relies on its technology platform and must protect sensitive patient data from cyber threats, data breaches, or system failures. Such incidents could harm the company's reputation, lead to regulatory penalties, and erode customer trust.
• Ability to Scale: Managing rapid growth while maintaining program quality, clinical efficacy, and customer satisfaction presents a challenge. Difficulties in scaling operations, technology infrastructure, or workforce could impede growth.
• Reliance on Key Personnel: The company's success depends significantly on attracting, retaining, and motivating highly skilled employees, particularly in technology, clinical, and sales roles.
• Impact of IPO: As a newly public company, Omada faces increased compliance costs and scrutiny, which could divert management's attention and resources. The market price of its common stock may be volatile.

---

4. Management's Discussion and Analysis (MD&A) Highlights

Management discusses the company's results of operations, liquidity, and capital resources, providing context for the financial statements.

• Results of Operations: Management primarily attributes the significant 35% revenue growth in 2025 to increased adoption of Omada's digital health programs and an expanding client base, reflecting strong market demand. While gross profit improved, the company continued to post a net loss, though smaller than the prior year. Strategic growth investments, particularly in R&D to enhance platform capabilities and develop new programs, and in S&M to expand market penetration and acquire new enterprise clients, directly caused this net loss. Increased G&A expenses also reflect the additional costs of operating as a public company. Management emphasizes these investments are critical for long-term growth and market leadership.
• Liquidity and Capital Resources: The successful June 2025 IPO significantly bolstered Omada's cash position, providing substantial capital for future operations and strategic initiatives. This infusion, combined with the existing credit facility, provides ample liquidity to fund ongoing operations, planned R&D, and S&M expansion. Management believes current cash and cash equivalents, anticipated operating cash flows, and available credit will sufficiently meet its working capital and capital expenditure needs for at least the next 12 months.
• Trends and Outlook: Management highlights the expanding digital health market and the increasing prevalence of chronic diseases as key tailwinds. The company's strategy leverages its clinical efficacy and integrated platform to capture a larger market share. Not using the extended transition period for new accounting standards reflects management's commitment to robust financial reporting as a public entity.

---

5. Financial Health

The IPO significantly strengthened Omada's financial position:

• Cash & Equivalents: As of December 31, 2025, cash and cash equivalents totaled $210 million, a substantial increase from $45 million at the end of 2024, largely thanks to IPO proceeds. This strong cash position provides significant financial flexibility.
• Working Capital: The company maintains a strong working capital position, crucial for funding operations and growth without immediate reliance on external financing.
• Debt: Omada has a $50 million credit facility with MidCap Financial Trust. Omada drew $20 million from this facility as of year-end 2025. This facility provides additional liquidity and flexibility for general corporate purposes, with an interest rate tied to the prime rate plus a margin. The company's overall debt level is manageable relative to its cash reserves and recent capital infusion.
• Capital Structure: Post-IPO, Omada's capital structure includes common stock, as all previously outstanding preferred stock converted to common shares. The company also has outstanding warrants, which, if exercised, could lead to future dilution and represent a potential future obligation.
• Related Party Transactions: Omada has commercial agreements with Cigna Ventures LLC, a venture capital arm of Cigna. Cigna Ventures is a "related party" due to its significant equity stake in Omada Health. This relationship offers strategic alignment and potential for future collaboration within the Cigna ecosystem but also requires careful management of potential conflicts of interest.

---

6. Future Outlook

Omada Health operates in the rapidly expanding digital health market, focusing on chronic disease prevention and management. Its strategy focuses on:

• Expanding Client Base: Partnering with large employers, health plans, and health systems to offer its programs, leveraging its proven clinical outcomes and integrated platform to attract new enterprise clients.
• Product Innovation: Investing in R&D to enhance existing programs (e.g., diabetes, hypertension, weight management) and develop new offerings to address a broader range of chronic conditions, ensuring its solutions lead the digital health space.
• Clinical Efficacy: Emphasizing evidence-based outcomes to demonstrate program value and cost-effectiveness, crucial for securing and retaining enterprise clients and driving market adoption.
• Market Opportunity: The company estimates its U.S. total addressable market at over $50 billion, driven by rising chronic disease prevalence and the shift towards value-based care. Omada aims to capture a significant portion of this market through strategic initiatives.
• Talent Incentivization: To attract, retain, and motivate its workforce, Omada established two new employee incentive programs in 2025: the 2025 Equity Incentive Plan and the 2025 Employee Stock Purchase Plan. These plans align employee interests with shareholder value creation by offering stock ownership opportunities, supporting long-term growth.

---

7. Competitive Position

The digital health market for chronic disease management is highly competitive and rapidly evolving. Omada Health competes with diverse entities, including:

• Traditional healthcare providers: Offer in-person or telehealth chronic care management services.
• Other digital health companies: Specialize in specific chronic conditions or offer broader digital health platforms.
• Large technology companies: Increasingly enter the healthcare space with digital solutions.
• Pharmaceutical companies: Expand into digital therapeutics and patient support programs.

Omada's competitive advantages and differentiators include:

• Clinical Efficacy and Evidence-Based Outcomes: Strong emphasis on demonstrating measurable health improvements and cost savings, critical for securing and retaining enterprise clients (employers, health plans).
• Integrated Platform and Personalized Approach: Combines professional health coaching, connected devices, and a proprietary digital platform for a comprehensive, personalized user experience.
• Enterprise Focus: A proven track record of partnering with large organizations, understanding their needs, and integrating into their benefits structures.
• Breadth of Programs: Offers solutions for multiple prevalent chronic conditions (diabetes, hypertension, weight management) and continuously invests in R&D to expand its offerings.
• Data-Driven Insights: Leverages platform data to continuously refine programs, improve user engagement, and demonstrate value.

This summary offers a comprehensive overview of Omada Health's performance and strategic position as a newly public company. For complete details and financial statements, investors should review the full 10-K filing.